Latest news with #JohnR.Adler
Business Wire
16-07-2025
- Business
- Business Wire
AIG Hospitals to Bring Cutting-Edge ZAP-X® Gyroscopic Radiosurgery® to South India
HYDERABAD, India--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that AIG Hospital in Hyderabad, India, will acquire the ZAP-X® Gyroscopic Radiosurgery® platform. Reinforcing its commitment to patient-centric innovation, AIG Hospitals will become the first hospital in South India to offer this revolutionary brain tumor treatment. This advancement will empower AIG Hospitals' neurosurgical team to deliver precision-focused care without the need for traditional open surgery, thereby redefining outcomes for patients with brain tumors and other intracranial conditions. Stereotactic Radiosurgery (SRS), widely accepted as an alternative to conventional brain surgery for many patients, is an incision-free outpatient procedure offering surgical-like precision with no anesthesia, and minimal recovery time. However, access to SRS has remained limited globally due to high infrastructure costs and radiation safety challenges. With ZAP-X, AIG Hospitals addresses these constraints while placing India on the global map of next-generation neurosurgical care. 'At AIG, our unwavering mission has always been to bring the most advanced, evidence-backed, and patient-focused medical technologies to India,' said Dr. D Nageshwar Reddy, Chairman, AIG Hospitals. 'The addition of ZAP-X exemplifies this vision. We believe this technology will be a game-changer for patients across India and neighboring regions who can now access world-class radiosurgery without the burden of travel, hospitalization, or surgical recovery.' Developed by Dr. John R. Adler, former Stanford professor of neurosurgery and radiation oncology, the ZAP-X platform is the world's first vault-free radiosurgery system, enabling installation without the need for costly radiation-shielded rooms. It also eliminates reliance on traditional Cobalt-60 radioactive sources, using a modern linear accelerator to deliver biologically consistent and efficient radiation doses. 'The strategic investment in ZAP-X is a reflection of our long-term vision to serve as a quaternary referral center for complex neurosurgical care, not only for India but for Southeast Asia, the Middle East, and Africa,' said Mr. PVS Raju, Vice-Chairman, AIG Hospitals. 'This platform expands our ability to handle high volumes with greater precision, while preserving patient quality of life through non-invasive care.' Built with a gyroscopic, dual-gimbaled design, ZAP-X offers a large spherical workspace to precisely direct radiation beams from thousands of potential angles and thereby reduce dose concentrations within healthy brain tissue. Along with real-time imaging, ultra-low scatter radiation, and sub-millimeter targeting accuracy, these novel advancements aim to improve outcomes for patients with brain metastases, meningiomas, acoustic neuromas, arteriovenous malformations, and trigeminal neuralgia. At the heart of this development lies AIG's Neurosurgical Program, led by Dr. Subodh Raju, Director & HOD, Neurosurgery, whose team will spearhead the clinical deployment of ZAP-X. 'ZAP-X is not just a technological upgrade, it is a paradigm shift,' said Dr. Subodh Raju. 'It enables us to precisely target even the most complex lesions while sparing healthy brain tissue. Patients walk in, undergo the pain-free session in a day-care setup, and walk out without hospitalization, or post-op recovery. This is the future of brain tumor treatment, and it will be now available in Hyderabad.' He added, 'The ability to offer repeat treatments when needed, patient-friendly immobilization without the rigid head frames of the past, and real-time dose monitoring puts this system at the forefront of radiosurgical safety and patient comfort.' With ZAP-X, AIG Hospitals strengthens its position as a neuroscience leader and becomes part of an elite global network of early adopters of this technology. This move aligns with the hospital's larger vision to bridge the gap between cutting-edge research and clinical practice while ensuring equitable access to life-saving innovations. About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn. About AIG Hospitals AIG Hospitals, Gachibowli is one of India's largest tertiary care, multi-specialty hospitals. With its 1000-bed capacity, 400+ consultant doctors and over 40 medical and surgical specialties, the hospital caters to more than 800,000 patients annually coming from all across India, Southeast Asia, Middle East and Africa. AIG is among only a few private hospitals in the country to have a fully functional Translational Research Facility where active bench to bedside research is undertaken in collaboration with many international and national institutes. Apart from being the highest volume center for Gastroenterology in the world with more than 30,000 therapeutic procedures, AIG centers of excellence include Cardiac Sciences, Neurosciences, Pulmonary Medicine, Oncology, and Renal and Bladder Sciences.
Business Wire
01-07-2025
- Business
- Business Wire
ZAP Surgical Systems and Ibn Sina Medical Center to Bring Groundbreaking Non-Invasive Brain Surgery Platform to Africa
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Ibn Sina Medical Center will become the first hospital in Morocco, and the first in Africa, to introduce the cutting-edge ZAP-X ® Gyroscopic Radiosurgery ® platform. This innovative non-invasive surgical robotics system is poised to transform brain cancer treatment across the region. Located in Casablanca, Ibn Sina Medical Center is a state-of-the-art facility currently under construction. The ZAP-X installation is scheduled to begin the summer of 2025, with the first patient treatments planned for fall of 2025. Stereotactic radiosurgery (SRS) is a completely non-invasive and painless outpatient procedure that has revolutionized the treatment of many primary and metastatic brain tumors, as well as other conditions affecting the brain, head, and neck. Typically completed in a single brief outpatient visit, SRS allows patients to often resume normal activities on the same day as treatment. Dr. Faouzi L' Habeeb, radiation and medical oncologist, managing partner and chairman at Ibn Sina Medical Center, commented, 'The ZAP-X platform signifies the future of brain tumor treatment, allowing us to improve patients' quality of life both throughout and following their treatment.' A primary motivation behind Ibn Sina Medical Center's acquisition of the ZAP-X system is its self-contained, self-shielded design. This unique feature eliminates the requirement for hospitals to build expensive, shielded radiation vaults. 'ZAP Surgical's mission is to make world-class stereotactic radiosurgery accessible to the millions of patients who currently lack access,' commented John R. Adler, MD, Professor Emeritus of Neurosurgery at Stanford University and Founder and CEO of ZAP Surgical Systems. 'By reducing the costs and complexities of traditional SRS delivery, ZAP aims to support providers such as Ibn Sina Medical Center and others around the globe with best-in-class care.' The ZAP-X system is also renowned for its innovative gyroscopic targeting, enabling radiosurgical beams to be delivered from thousands of potential angles. This pioneering approach enhances precision by hyper-focusing radiation to intracranial lesions while also minimizing radiation exposure to healthy brain tissue, thus helping to preserve patient cognitive function. Additionally, ZAP-X is the first and only dedicated cranial radiosurgery platform to eliminate the need for Cobalt-60 radioactive isotopes. Instead, it employs a modern linear accelerator to generate radiation, removing the costs and logistical challenges associated with acquiring, securing, and regularly replacing potentially dangerous radioactive materials. 'The entire ZAP team is honored to work alongside Dr. L' Habeeb and the clinical team at Ibn Sina Medical Center,' said Ahmed Salem, Regional Business Director for ZAP Surgical. 'With the addition of ZAP-X, they continue a proud tradition of bringing the latest and most advanced radiation delivery technologies to Morocco.' The successful introduction of this cutting-edge technology to Morocco was spearheaded by Issam Fadil and Faisal Khalil Jouhari of Promedstore Imaging, the official regional distributor of ZAP-X. For more information about ZAP-X, please visit About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X ® Gyroscopic Radiosurgery ® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife ® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn.
The Star
10-05-2025
- Health
- The Star
Vietnam FV Hospital in HCM City invests in AI-powered system for cancer treatment
HO CHI MINH CITY (Bernama-VNA): FV Hospital in Ho Chi Minh City has announced its investment in a cutting-edge robotic radiosurgery device integrated with artificial intelligence (AI), the first of its kind in Vietnam. According to the Vietnam News Agency (VNA), the CyberKnife S7 system, valued at nearly 200 billion VND (approximately US$8 million), enables the treatment of tumours anywhere in the body without surgery, marking a major advance in non-invasive, highly precise cancer therapy. According to Dr Jean-Marcel Guillon, CEO of FV Hospital, the CyberKnife system was first developed in 1990 by Dr John R. Adler, a neurosurgeon at Stanford University in the United States. Now in its seventh generation, the system has been clinically validated in more than 5,000 scientific publications. With its ability to accurately target tumours across the body, CyberKnife S7 represents a global revolution in minimally invasive radiosurgery. What sets the CyberKnife S7 apart is its real-time image-guidance technology and robotic arm, which combines a 6MV linear accelerator with full 3D mobility, allowing sub-millimetre targeting precision. Powered by Synchrony technology and AI, the system automatically adjusts radiation beams in real time to account for tumour movement caused by respiration or internal organ motion, such as in the lungs, liver, or prostate. This eliminates the need for traditional immobilisation equipment or breath-hold techniques, reducing side effects and enhancing patient comfort and treatment outcomes. Treatment duration is significantly reduced, requiring just one to five sessions compared to 10 to 40 with conventional radiotherapy. Dr Basma M'Barek, Head of FV's Hy Vong Cancer Centre, said the system is especially beneficial for treating difficult-to-access or recurrent tumours, as well as cancers located near vital organs. It can also be used to treat certain non-cancerous conditions, such as brain arteriovenous malformations and cardiac arrhythmias, which are typically beyond the capabilities of standard radiotherapy machines. By pioneering this technology, FV Hospital aims to expand access to advanced cancer care in Vietnam, reduce the need for overseas treatment, and meet the growing demand from foreign residents and medical tourists. Notably, CyberKnife S7 treatment is covered under Vietnam's national health insurance scheme. - Bernama-VNA
